Brind.

Assembly Biosciences appointed Jeanette M. Bjorkquist as CFO and began a collaboration with Gilead Sciences for virology therapies research.

1 report, 0 independent Updated Jul 3
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Assembly Biosciences appointed Jeanette M. Bjorkquist as CFO and began a collaboration with Gilead Sciences for virology therapies research.

Who's involved

What this event is mainly about
Assembly Biosciences (United States)Gilead Sciences

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • Unknown outlet